Date | Time | Source | Announcement |
---|---|---|---|
28 Feb 2003 | 12:51 PM | Director Shareholding | |
27 Feb 2003 | 05:04 PM | Purchase of Own Securities | |
27 Feb 2003 | 03:32 PM | Director Shareholding | |
26 Feb 2003 | 05:21 PM | Director Shareholding | |
26 Feb 2003 | 03:23 PM | Director Shareholding | |
25 Feb 2003 | 05:03 PM | Purchase of Own Securities | |
24 Feb 2003 | 06:14 PM | Director Shareholding | |
24 Feb 2003 | 06:07 PM | Director Shareholding | |
24 Feb 2003 | 05:09 PM | Purchase of Own Securities | |
24 Feb 2003 | 04:22 PM | Director Shareholding | |
21 Feb 2003 | 05:01 PM | Purchase of Own Securities | |
21 Feb 2003 | 04:33 PM | Holding(s) in Company | |
19 Feb 2003 | 04:55 PM | Purchase of Own Securities | |
18 Feb 2003 | 04:58 PM | Purchase of Own Securities | |
17 Feb 2003 | 04:59 PM | Director Shareholding | |
17 Feb 2003 | 04:57 PM | Director Shareholding | |
17 Feb 2003 | 03:15 PM | Director Shareholding | |
14 Feb 2003 | 05:09 PM | Director Shareholding | |
13 Feb 2003 | 04:55 PM | Purchase of Own Securities | |
13 Feb 2003 | 12:10 PM | Director Shareholding | |
12 Feb 2003 | 12:00 PM | Final Results | |
10 Feb 2003 | 03:40 PM | Directorate Change | |
10 Feb 2003 | 01:48 PM | Director Shareholding | |
07 Feb 2003 | 03:39 PM | Director Shareholding | |
03 Feb 2003 | 05:43 PM | Director Shareholding | |
03 Feb 2003 | 05:41 PM | Director Shareholding | |
03 Feb 2003 | 04:33 PM | Director Shareholding | |
03 Feb 2003 | 04:22 PM | Director Shareholding | |
28 Jan 2003 | 03:21 PM | Director Shareholding | |
27 Jan 2003 | 04:28 PM | Director Shareholding-Replace | |
27 Jan 2003 | 02:43 PM | Blocklisting Interim Review | |
27 Jan 2003 | 02:20 PM | Director Shareholding | |
23 Jan 2003 | 05:39 PM | Positive Opinion - Seretide | |
21 Jan 2003 | 12:50 PM | Director Shareholding | |
21 Jan 2003 | 10:02 AM | Director Shareholding | |
21 Jan 2003 | 09:58 AM | Director Shareholding | |
17 Jan 2003 | 03:25 PM | Director Shareholding | |
15 Jan 2003 | 07:00 AM | Paxil Litigation Update | |
13 Jan 2003 | 04:57 PM | Director Shareholding | |
13 Jan 2003 | 12:04 PM | Director Shareholding | |
10 Jan 2003 | 03:09 PM | Director Shareholding | |
10 Jan 2003 | 03:04 PM | Director Shareholding | |
08 Jan 2003 | 05:23 PM | Director Shareholding | |
08 Jan 2003 | 04:39 PM | Director Shareholding | |
07 Jan 2003 | 03:51 PM | Director Shareholding | |
07 Jan 2003 | 03:49 PM | Director Shareholding | |
07 Jan 2003 | 03:43 PM | Director Shareholding | |
07 Jan 2003 | 11:14 AM | Director Shareholding | |
06 Jan 2003 | 05:31 PM | Director Shareholding | |
06 Jan 2003 | 04:30 PM | Director Shareholding |
GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.
The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.
In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.
GSK share price launched at 346p in 1989.